![Ted Jenkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Ted Jenkins, formerly the Senior Director-Investor Relations at Corbus Pharmaceuticals Holdings, Inc. from 2017 to 2021, and later the VP-Investor Relations & Strategic Finance at Spero Therapeutics, Inc. from 2021 to 2024.
Eerdere bekende functies van Ted Jenkins
| Bedrijven | Functie | Einde |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Investor Relations Contact | 01-03-2024 |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Investor Relations Contact | 01-07-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
6
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
